e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
COPD - pathogenesis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS
A. Plymoth, Z. Yang, C. G. Lofdahl, A. Ekberg-Jansson, M. Dahlback, T. E. Fehniger, G. Marko-Varga, W. S. Hancock (Lund, Gothenburg, Sweden; Boston, United States Of America)
Source:
Annual Congress 2005 - COPD - pathogenesis I
Session:
COPD - pathogenesis I
Session type:
Thematic Poster Session
Number:
440
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Plymoth, Z. Yang, C. G. Lofdahl, A. Ekberg-Jansson, M. Dahlback, T. E. Fehniger, G. Marko-Varga, W. S. Hancock (Lund, Gothenburg, Sweden; Boston, United States Of America). Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS. Eur Respir J 2005; 26: Suppl. 49, 440
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach
Source: Eur Respir J 2003; 21: 414-420
Year: 2003
Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010
Breath analysis by ion mobility spectrometry in sarcoidosis – results of a feasibility study
Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Year: 2008
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Relative protein expression in normal bronchoalveolar lavage fluid (BALF) quantified via shotgun proteomics and stable isotope free methods
Source: Eur Respir J 2006; 28: Suppl. 50, 813s
Year: 2006
Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis
Source: Eur Respir J 2013; 41: 1331-1339
Year: 2013
Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study
Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021
Year: 2022
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry
Source: Eur Respir J 2004; 24: Suppl. 48, 213s
Year: 2004
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Comparative study of three different methods of breath sampling for VOCs detection using IMS analyzer
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Analysis of exhaled breath condensate proteom and BAL Proteom by matrix assisted laser desorption/ioniosation – time of flight (MALDI-TOF) from patients with acute lung injury
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept